A comprehensive search of functional sequence space using large mammalian display libraries created by gene editing.


Journal

mAbs
ISSN: 1942-0870
Titre abrégé: MAbs
Pays: United States
ID NLM: 101479829

Informations de publication

Date de publication:
07 2019
Historique:
pubmed: 21 5 2019
medline: 15 2 2020
entrez: 21 5 2019
Statut: ppublish

Résumé

The construction of large libraries in mammalian cells allows the direct screening of millions of molecular variants for binding properties in a cell type relevant for screening or production. We have created mammalian cell libraries of up to 10 million clones displaying a repertoire of IgG-formatted antibodies on the cell surface. TALE nucleases or CRISPR/Cas9 were used to direct the integration of the antibody genes into a single genomic locus, thereby rapidly achieving stable expression and transcriptional normalization. The utility of the system is illustrated by the affinity maturation of a PD-1-blocking antibody through the systematic mutation and functional survey of 4-mer variants within a 16 amino acid paratope region. Mutating VH CDR3 only, we identified a dominant "solution" involving substitution of a central tyrosine to histidine. This appears to be a local affinity maximum, and this variant was surpassed by a lysine substitution when light chain variants were introduced. We achieve this comprehensive and quantitative interrogation of sequence space by combining high-throughput oligonucleotide synthesis with mammalian display and flow cytometry operating at the multi-million scale.

Identifiants

pubmed: 31107136
doi: 10.1080/19420862.2019.1618673
pmc: PMC6601556
doi:

Substances chimiques

Antibodies, Monoclonal, Humanized 0
Complementarity Determining Regions 0
Immunoglobulin Heavy Chains 0
Programmed Cell Death 1 Receptor 0
Endodeoxyribonucleases EC 3.1.-

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

884-898

Références

Stem Cells Transl Med. 2014 Jul;3(7):821-35
pubmed: 24833591
Proc Natl Acad Sci U S A. 2008 Sep 23;105(38):14336-41
pubmed: 18812621
Cell Mol Immunol. 2012 Mar;9(2):184-90
pubmed: 22179672
Biotechnol Bioeng. 2013 Mar;110(3):871-80
pubmed: 23042119
Nat Biotechnol. 2011 Mar;29(3):245-54
pubmed: 21390033
Proc Natl Acad Sci U S A. 1988 May;85(10):3435-9
pubmed: 2835772
Mol Cell Biol. 1994 Dec;14(12):8096-106
pubmed: 7969147
Nucleic Acids Res. 2018 Aug 21;46(14):7436-7449
pubmed: 29931269
Science. 2011 Sep 30;333(6051):1843-6
pubmed: 21960622
Science. 2014 Jan 3;343(6166):80-4
pubmed: 24336569
Anal Biochem. 2011 Oct 1;417(1):25-35
pubmed: 21704603
MAbs. 2016 May-Jun;8(4):726-40
pubmed: 26986818
Science. 2003 May 2;300(5620):763
pubmed: 12730593
Science. 2014 Jan 3;343(6166):84-87
pubmed: 24336571
Proc Natl Acad Sci U S A. 2013 Oct 29;110(44):17802-7
pubmed: 24082130
Proc Natl Acad Sci U S A. 2012 Sep 25;109(39):15728-33
pubmed: 23019357
J Mol Biol. 1992 Mar 20;224(2):487-99
pubmed: 1560463
PLoS One. 2013;8(2):e54072
pubmed: 23457446
MAbs. 2010 Sep-Oct;2(5):508-18
pubmed: 20716968
Nat Commun. 2016 Aug 17;7:12535
pubmed: 27531490
Sci Rep. 2017 Aug 21;7(1):9000
pubmed: 28827556
Bioessays. 2014 Jan;36(1):34-8
pubmed: 24323919
Int J Mol Sci. 2015 Oct 09;16(10):23849-66
pubmed: 26473830
Nucleic Acids Res. 2017 Jun 20;45(11):e102
pubmed: 28335006
Nat Rev Cancer. 2011 Dec 01;12(1):51-8
pubmed: 22129804
Genome Biol. 2007;8(11):R254
pubmed: 18047641
BMC Biotechnol. 2006 Dec 22;6:49
pubmed: 17187663
Nat Biotechnol. 2005 Oct;23(10):1257-68
pubmed: 16211069
Trends Genet. 2008 Nov;24(11):529-38
pubmed: 18809224
Nat Protoc. 2006;1(2):755-68
pubmed: 17406305
Methods. 2014 Jan 1;65(1):57-67
pubmed: 24036249

Auteurs

Kothai Parthiban (K)

a IONTAS Ltd , Cambridge , UK.

Rajika L Perera (RL)

a IONTAS Ltd , Cambridge , UK.

Maheen Sattar (M)

a IONTAS Ltd , Cambridge , UK.

Yanchao Huang (Y)

a IONTAS Ltd , Cambridge , UK.

Sophie Mayle (S)

a IONTAS Ltd , Cambridge , UK.

Edward Masters (E)

a IONTAS Ltd , Cambridge , UK.

Daniel Griffiths (D)

a IONTAS Ltd , Cambridge , UK.

Sachin Surade (S)

a IONTAS Ltd , Cambridge , UK.

Rachael Leah (R)

a IONTAS Ltd , Cambridge , UK.

Michael R Dyson (MR)

a IONTAS Ltd , Cambridge , UK.

John McCafferty (J)

a IONTAS Ltd , Cambridge , UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH